Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients

Maureen J. Donlin; Nathan A. Cannon; Rajeev Aurora; Jia Li; Abdus S. Wahed; Adrian M. Di Bisceglie; John E. Tavis; for the Virahep-C Study Group

doi:10.1371/journal.pone.0009032

Loading metrics

Open Access

Peer-reviewed

Research Article

Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients

Maureen J. Donlin,

Affiliations Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America, Saint Louis University Liver Center, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America
⨯
Nathan A. Cannon,

Affiliation Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America
⨯
Rajeev Aurora,

Affiliation Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America
⨯
Jia Li,

Affiliation Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
⨯
Abdus S. Wahed,

Affiliation Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
⨯
Adrian M. Di Bisceglie,

Affiliations Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America, Saint Louis University Liver Center, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America
⨯
John E. Tavis ,

* E-mail: tavisje@slu.edu

Affiliations Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America, Saint Louis University Liver Center, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America
⨯
for the Virahep-C Study Group

Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients

Maureen J. Donlin,
Nathan A. Cannon,
Rajeev Aurora,
Jia Li,
Abdus S. Wahed,
Adrian M. Di Bisceglie,
John E. Tavis,
for the Virahep-C Study Group

Published: February 3, 2010
https://doi.org/10.1371/journal.pone.0009032

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Human genetics
Is the Subject Area "Human genetics" applicable to this article?

Thanks for your feedback.
Genetic polymorphism
Is the Subject Area "Genetic polymorphism" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Viral genetics
Is the Subject Area "Viral genetics" applicable to this article?

Thanks for your feedback.
Interferons
Is the Subject Area "Interferons" applicable to this article?

Thanks for your feedback.
Genetic interference
Is the Subject Area "Genetic interference" applicable to this article?

Thanks for your feedback.
Sequence alignment
Is the Subject Area "Sequence alignment" applicable to this article?

Thanks for your feedback.